|
BCDA
|
BioCardia, Inc.
|
US
|
NASDAQ
|
|
BLPH
|
Bellerophon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CGTX
|
Cognition Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IKT
|
Inhibikase Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
US
|
NASDAQ
|
|
NVCR
|
NovoCure Limited
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
US
|
NASDAQ
|
|
UBX
|
Unity Biotechnology, Inc.
|
US
|
NASDAQ
|
|
ACW
|
Actinogen Medical Ltd
|
AU
|
ASX
|
|
CGNSF
|
Cognetivity Neurosciences Ltd
|
US
|
OTC
|
|
KHTRF
|
Knight Therapeutics
|
US
|
OTC
|
|
IXI
|
Ixico Plc
|
UK
|
LSE
|
|
BRAINP
|
Brain+ ApS
|
DK
|
CO
|
|
ALQGC
|
Quantum Genomics SA
|
FR
|
PA
|
|
ACARIX
|
Acarix A/S
|
SE
|
ST
|
|
ELIC
|
Elicera Therapeutics AB
|
SE
|
ST
|
|
WENA
|
Anew Medical, Inc.
|
US
|
US
|
|
WENAW
|
Anew Medical, Inc.
|
US
|
US
|
|
07X
|
ANNOVIS BIO INC. DL-0001
|
DE
|
F
|
|
23I
|
Intra-Cellular Therapies Inc
|
DE
|
F
|